Skip to main content

Lenvaxen 4 mg & 10 mg (Lenvatinib)

Lenvatinib can cause adverse reactions ranging from manageable effects to potentially serious complications. The likelihood and severity can vary according to the treatment indication, dose, combination therapy and individual patient factors.

Commonly reported adverse reactions

Reported reactions can include:

  • Hypertension
  • Fatigue
  • Diarrhea
  • Decreased appetite
  • Weight loss
  • Nausea
  • Stomatitis
  • Proteinuria
  • Hand-foot syndrome
  • Vomiting
  • Hypothyroidism or thyroid-function abnormalities
  • Musculoskeletal symptoms
  • Headache

The exact frequency differs between clinical trials and indications, so a single frequency table should not be generalized to every patient population.

Serious adverse reactions

The prescribing information identifies important risks involving:

RiskClinical concern
HypertensionBlood pressure can become significantly elevated
Cardiac dysfunctionReduced cardiac function can occur
Arterial thromboembolismArterial blood clots can cause serious events
HepatotoxicityLiver injury or impaired liver function
Renal impairmentKidney dysfunction or renal failure
ProteinuriaIncreased urinary protein
DiarrheaCan become clinically significant
GI perforation/fistulaRare but serious gastrointestinal complications
QT prolongationCan increase risk of abnormal cardiac rhythms
HypocalcemiaLow blood calcium
PRES/RPLSNeurologic syndrome associated with brain edema
HemorrhageSerious bleeding
Wound-healing impairmentDelayed healing
Osteonecrosis of the jawJaw-bone injury
Embryo-fetal toxicityPotential fetal harm

When urgent medical attention may be required

Prompt medical assessment may be appropriate for symptoms suggesting severe hypertension, chest pain, severe shortness of breath, neurologic changes, significant bleeding, severe abdominal symptoms, seizures, confusion, visual disturbance or other potentially serious reactions.

Monitoring

Monitoring may include blood pressure, renal and hepatic function, urine protein, thyroid function, electrolytes and clinical assessment for cardiovascular or neurologic complications.